Piper Sandler Companies (PIPR) has entered Q1 2026 with trailing 12 month revenue of about US$1.9b and basic EPS of US$4.22. This is alongside year over year earnings growth of 55.3% and revenue growth of 9.8%. Over the past reported quarters, total revenue has moved from US$484.1 million in Q4 2024 to US$666.1 million in Q4 2025, while quarterly basic EPS has ranged from US$0.55 in Q3 2024 to US$1.69 in Q4 2025. Taken together, these figures present a picture of improving profitability and firmer margins for the latest print.
See our full analysis for Piper Sandler Companies.With the recent results on the table, the next step is to set these margin trends against the widely held narratives around Piper Sandler Companies to see which stories hold up and which look out of sync with the numbers.
See what the community is saying about Piper Sandler Companies
14.8% Net Margin Points To Earnings Power
- Trailing net profit margin sits at 14.8%, compared with 11.9% a year earlier, on trailing revenue of about US$1.9b and net income of US$281.3 million.
- Consensus narrative highlights complex advisory work in areas like bank M&A, private credit and municipal finance as key fee pools, and the current 14.8% margin offers a reality check on that view.
- Advisory heavy themes such as bank consolidation and private capital work are consistent with a margin profile that has moved from 11.9% to 14.8% while trailing revenue rose 9.8% per year.
- At the same time, revenue growth has been slower than the 11.1% US market benchmark, which means the higher margin is carrying more of the load than top line acceleration.
55.3% Earnings Growth With Slower 9.8% Revenue Pace
- Earnings climbed 55.3% over the last 12 months, compared with 9.8% annual revenue growth and a 2.9% per year earnings pace over five years.
- The consensus narrative leans on growing fee opportunities in healthcare, biotech and technology focused sectors, and the sharp 55.3% earnings lift raises questions about how much is structural versus cyclical.
- Sector themes like active healthcare and biotech financings line up with quarterly revenue stepping from US$357.3 million in Q1 2025 to US$666.1 million in Q4 2025, which helps explain the outsized earnings move.
- However, the much gentler 2.9% five year earnings growth rate shows that the recent 55.3% jump is a short period of strength rather than a long running trend in the numbers provided.
P/E Of 20.1x Versus DCF Fair Value
- Piper Sandler trades on a trailing P/E of 20.1x at a share price of US$79.42, below the US Capital Markets industry average of 41.9x and a peer average of 21.5x, while the supplied DCF fair value is US$25.47.
- Consensus narrative points to long term earnings potential across private credit, technology and public finance, yet the gap between the current price and the DCF fair value introduces a clear tension.
- The lower than industry P/E multiple lines up with the idea that investors are not paying the same earnings multiple as the broader Capital Markets group even after a 55.3% earnings lift and 14.8% net margin.
- On the other hand, a DCF fair value of US$25.47 compared with a US$79.42 share price suggests the provided cash flow model is much more conservative than the consensus narrative that expects higher revenues and margins over time.
If you want to see how other companies with healthier balance sheets and fundamentals stack up on valuation and growth, it can help to scan a focused list rather than look at PIPR in isolation using the solid balance sheet and fundamentals stocks screener (44 results)
Next Steps
To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Piper Sandler Companies on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.
After weighing the stronger margins against that conservative DCF, the real question is how you read the balance of risk and reward here. Move quickly from headline numbers to the underlying drivers, and then ground your own view with the 2 key rewards and 1 important warning sign
See What Else Is Out There
The sharp 55.3% earnings jump alongside a 9.8% revenue pace and a share price well above the supplied DCF fair value highlights valuation tension and potential fragility in recent strength.
If that gap between earnings momentum and the conservative cash flow value makes you cautious about paying up here, it is worth scanning the 51 high quality undervalued stocks to quickly focus on companies where pricing and fundamentals currently look more aligned.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com